Krishnan Nandabalan - Director, Bioxcel Therapeutics, Inc

As of June 29, 2021


Krishnan Nandabalan Net Worth

  • Net worth is estimated to be at least $252.17M
  • Owns at least 8,546,750 units of Bioxcel Therapeutics, Inc stock
  • Sold an estimated value of $33.34M in the last 3 years at Bioxcel Therapeutics, Inc

Krishnan Nandabalan Trading

  • Largest purchase of shares was 1,000 units , worth over $4.92K on November 30, 2018
  • Largest sale of shares was 473,250 units , worth over $14.59M on June 29, 2021
  • In total has made about 5 transactions over 3 years
  • Usually trades in April, May, November, February and June, with the busiest year in 2021 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Krishnan Nandabalan Mailing Address

  • Mailing address is 228 Village Pond Road Guilford CT 06437 CT

Bioxcel Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Vimal Mehta, Ph.D. 2020 $890,000 - $8,122,500 $556,250 $7,800 $9,576,550
Vimal Mehta, Ph.D. 2019 $459,000 - $1,269,131 $233,000 $7,800 $1,968,931
William P. Kane, Jr. 2020 $245,455 - $4,185,500 $138,699 - $4,569,654
Reina Benabou, M.D., Ph.D. 2020 $197,443 - $2,462,400 $76,341 - $2,736,184
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1720893/000110465921055605/tm212482-3_def14a.htm

Bioxcel Therapeutics, Inc Insider Trading

  • The most recent transaction was 473,250 units sold on June 29, 2021 by Vimal Mehta worth over $14.59M
  • In the last 3 years, insiders at Bioxcel Therapeutics, Inc sold an estimated value of $131.43M and bought an estimated value of $19.96M
  • The most active traders are Vimal Mehta, CEO,  Frank Yocca, Chief Scientific Officer,  and Peter Mueller, Director
  • Insider trading is most common in March, with the busiest year in 2021

BioXcel Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1